Skip to Main Content

Author Details

Fran??ois Meyer
Laval University
1986
89
39
PMIDPaper TitleJournal TitlePublished Year
30651130A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.J Otolaryngol Head Neck Surg2019
28766373Prediction of the outcome of children who had a language delay at age 2 when they are aged 4: Still a challenge.Int J Speech Lang Pathol2018
29951282Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients.Cancers Head Neck2018
26702991Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer.Radiother Oncol2016
27173062A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways.Cancer Epidemiol2016
23169318Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients.Int J Cancer2013
21424341Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.Support Care Cancer2012
22076708Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.Clin Cancer Res2012
22009713Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.Cancer2012
21640495Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.Int J Radiat Oncol Biol Phys2012
20533282Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.Int J Cancer2011
20103685Serum prognostic markers in head and neck cancer.Clin Cancer Res2010
20825973Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.Hum Pathol2010
20530383Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme.J Speech Lang Hear Res2010
20187097Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.Cancer2010
19451440Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.J Clin Oncol2009
17885825Systematic review of the literature on characteristics of late-talking toddlers.Int J Lang Commun Disord2008
18838726Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.Ann Intern Med2008
18543328Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough?Cancer2008
18329693Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.Hum Pathol2008
18349267Genetic polymorphisms and head and neck cancer outcomes: a review.Cancer Epidemiol Biomarkers Prev2008
18059031Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients.Int J Cancer2008
18172254Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.Clin Cancer Res2008
17927499Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.Nutr Cancer2007
16643266Women's perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer.Eur J Cancer Care (Engl)2006
17078346Implementing the role of patient-navigator nurse at a university hospital centre.Can Oncol Nurs J2006
17076947Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.Can J Urol2006
17116715Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome.J Nutr2006
16841333Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.Int J Cancer2006
15800922Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.Int J Cancer2005
16172243A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.Cancer Epidemiol Biomarkers Prev2005
15826765Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.Eur Urol2005
15812073A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.J Natl Cancer Inst2005
16027437Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.J Clin Oncol2005
15280632Antihypertensive drug use and the risk of prostate cancer (Canada).Cancer Causes Control2004
12772004Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.Can J Gastroenterol2003
14679018Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.Cancer Res2003
12845682Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.Int J Cancer2003
11898936PSA screening and prostate cancer mortality.CMAJ2002
11502434Overview consensus statement.Urology2001
11307144Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.Int J Cancer2001
11502453Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer.Urology2001
10607740P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.Carcinogenesis2000
11175346Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.Oncogene2000
11065013Lifetime occupational physical activity and incidental prostate cancer (Canada).Cancer Causes Control2000
10719738Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.Int J Cancer2000
10480692Psychological stress and incidence of ischaemic heart disease.Int J Epidemiol1999
10393843Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.Am J Pathol1999
10325493Dietary fat and prostate cancer progression and survival.Eur Urol1999
10081867Downward trend in prostate cancer mortality in Quebec and Canada.J Urol1999
  • 1 - 50 of 89

Recommended Authors

School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year 2007
Number of shared co-authors 0
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 2
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
Virginia Tech
Career Start Year 1994
Number of shared co-authors 0
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 2
University of Toronto Dalla Lana School of Public Health
Career Start Year 1988
Number of shared co-authors 3
University of California irvine
Career Start Year 1988
Number of shared co-authors 4
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 4
School of Public Health and Health Professions, University at Buffalo
Career Start Year 1985
Number of shared co-authors 3
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 5
University at Buffalo
Career Start Year 1984
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 1983
Number of shared co-authors 2
Brigham and Women's Hospital
Career Start Year 1982
Number of shared co-authors 4
University of Southern California
Career Start Year 1981
Number of shared co-authors 3
Albert Einstein College of Medicine
Career Start Year 1980
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 2
Fred Hutchinson Cancer Research Center
Career Start Year 1980
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 4
Comprehensive Cancer Center, The Ohio State University
Career Start Year 1978
Number of shared co-authors 1
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 1974
Number of shared co-authors 6
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1973
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1973
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 1972
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1971
Number of shared co-authors 4
University of California San Francisco
Career Start Year 1968
Number of shared co-authors 1
University of Southern California
Career Start Year 1967
Number of shared co-authors 5
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 1964
Number of shared co-authors 2
Memorial Sloan-Kettering Cancer Center
Career Start Year 1963
Number of shared co-authors 3

Collaborators

Laval University Cancer Research Center
Co-authored papers 47
CHU de Quebec-Universite Laval
Co-authored papers 24
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 22
Laval University, CHU de Quebec
Co-authored papers 11
CHU de Quebec-Universite Laval
Co-authored papers 10
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 8
Princess Margaret Cancer Centre
Co-authored papers 6
Centre Hospitalier Universitaire de Quebec
Co-authored papers 4
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 4
University Health Network
Co-authored papers 4
University of Dhaka
Co-authored papers 4
Institut du cancer de Montreal
Co-authored papers 3
SLR Consulting (Canada) Ltd
Co-authored papers 3
Co-authored papers 3
Princess Margaret Cancer Centre
Co-authored papers 3
Memorial University
Co-authored papers 2
Co-authored papers 2
Princess Margaret Cancer Centre and University Health Network, University of Toronto
Co-authored papers 2
Co-authored papers 1
The Ottawa Hospital Research Institute
Co-authored papers 1
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 1
Toronto General Hospital
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1